143 related articles for article (PubMed ID: 16920101)
1. Comparison of the neurotoxic effects of proteasomal inhibitors in primary mesencephalic cultures.
Reaney SH; Johnston LC; Langston WJ; Di Monte DA
Exp Neurol; 2006 Dec; 202(2):434-40. PubMed ID: 16920101
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models.
Sun F; Anantharam V; Zhang D; Latchoumycandane C; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2006 Sep; 27(5):807-15. PubMed ID: 16870259
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions, but do not up-regulate iHSP70, following proteasomal inhibition.
Rideout HJ; Lang-Rollin IC; Savalle M; Stefanis L
J Neurochem; 2005 Jun; 93(5):1304-13. PubMed ID: 15934949
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of proteasome activity sensitizes dopamine neurons to protein alterations and oxidative stress.
Mytilineou C; McNaught KS; Shashidharan P; Yabut J; Baptiste RJ; Parnandi A; Olanow CW
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1237-51. PubMed ID: 15480836
[TBL] [Abstract][Full Text] [Related]
5. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures.
McNaught KS; Mytilineou C; Jnobaptiste R; Yabut J; Shashidharan P; Jennert P; Olanow CW
J Neurochem; 2002 Apr; 81(2):301-6. PubMed ID: 12064477
[TBL] [Abstract][Full Text] [Related]
6. Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia.
Peng GS; Li G; Tzeng NS; Chen PS; Chuang DM; Hsu YD; Yang S; Hong JS
Brain Res Mol Brain Res; 2005 Mar; 134(1):162-9. PubMed ID: 15790540
[TBL] [Abstract][Full Text] [Related]
7. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.
Lannuzel A; Michel PP; Höglinger GU; Champy P; Jousset A; Medja F; Lombès A; Darios F; Gleye C; Laurens A; Hocquemiller R; Hirsch EC; Ruberg M
Neuroscience; 2003; 121(2):287-96. PubMed ID: 14521988
[TBL] [Abstract][Full Text] [Related]
8. Differential sensitivity of mesencephalic neurons to inhibition of phosphatase 2A.
Zeevalk GD; Bernard LP; Manzino L; Sonsalla PK
J Pharmacol Exp Ther; 2001 Sep; 298(3):925-33. PubMed ID: 11504786
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of dieldrin for dopaminergic neurons in mesencephalic cultures.
Sanchez-Ramos J; Facca A; Basit A; Song S
Exp Neurol; 1998 Apr; 150(2):263-71. PubMed ID: 9527896
[TBL] [Abstract][Full Text] [Related]
10. Acute neurotoxic effects of mancozeb and maneb in mesencephalic neuronal cultures are associated with mitochondrial dysfunction.
Domico LM; Zeevalk GD; Bernard LP; Cooper KR
Neurotoxicology; 2006 Sep; 27(5):816-25. PubMed ID: 16889834
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
Ganser C; Papazoglou A; Just L; Nikkhah G
Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
[TBL] [Abstract][Full Text] [Related]
12. GDNF family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon.
Ducray A; Krebs SH; Schaller B; Seiler RW; Meyer M; Widmer HR
Brain Res; 2006 Jan; 1069(1):104-12. PubMed ID: 16380100
[TBL] [Abstract][Full Text] [Related]
13. Effect of proteasome inhibitor on cultured mesencephalic dopaminergic neurons.
Kikuchi S; Shinpo K; Tsuji S; Takeuchi M; Yamagishi S; Makita Z; Niino M; Yabe I; Tashiro K
Brain Res; 2003 Feb; 964(2):228-36. PubMed ID: 12576183
[TBL] [Abstract][Full Text] [Related]
14. The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.
McNaught KS; Jnobaptiste R; Jackson T; Jengelley TA
Synapse; 2010 Mar; 64(3):241-50. PubMed ID: 19924695
[TBL] [Abstract][Full Text] [Related]
15. Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition.
Miwa H; Kubo T; Suzuki A; Nishi K; Kondo T
Neurosci Lett; 2005 May 20-27; 380(1-2):93-8. PubMed ID: 15854758
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibitor lactacystin disturbs the intracellular calcium homeostasis of dopamine neurons in ventral mesencephalic cultures.
Li X; Yang D; Li L; Peng C; Chen S; Le W
Neurochem Int; 2007 Jun; 50(7-8):959-65. PubMed ID: 17561309
[TBL] [Abstract][Full Text] [Related]
18. Genistein protects dopaminergic neurons by inhibiting microglial activation.
Wang X; Chen S; Ma G; Ye M; Lu G
Neuroreport; 2005 Feb; 16(3):267-70. PubMed ID: 15706233
[TBL] [Abstract][Full Text] [Related]
19. Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways.
Collo G; Bono F; Cavalleri L; Plebani L; Merlo Pich E; Millan MJ; Spano PF; Missale C
J Neurochem; 2012 Mar; 120(5):765-78. PubMed ID: 22145570
[TBL] [Abstract][Full Text] [Related]
20. Glia-conditioned medium induces de novo synthesis of tyrosine hydroxylase and increases dopamine cell survival by differential signaling pathways.
de Bernardo S; Canals S; Casarejos MJ; Rodriguez-Martin E; Mena MA
J Neurosci Res; 2003 Sep; 73(6):818-30. PubMed ID: 12949908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
